Engaging Patients with Small Cell Lung Cancer in Clinical Trials

Many patients with SCLC have a high symptom burden, poor prognosis, adherence challenges due to treatment-related adverse events, stigmatization, and emotional distress. Clinical trials are taking place across the country for patients with all stages of small cell lung cancer. CANCER BUZZ spoke to David Waterhouse, MD, MPH, Medical Oncologist and Hematologist at the Dana-Farber Brigham Cancer Center, Milford Regional Medical Center in Milford, MA. Hear how to engage patients in clinical trials and address barriers.  "Eighty-five percent (85%) of cancer care is being done in the community, not at academic centers such as ours. And so, you have to be able to meet the patient where they are. I don't think we do a very good job of that right now, as an oncologic community." David Waterhouse, MD, MPH Medical Oncologist and Hematologist Dana-Farber Brigham Cancer Center  Milford Regional Medical Center Milford, MA      Resources:  Cancer Support Community ClinicalTrials.gov Go2 for Lung Cancer LUNGEVITY Lung Cancer Research Foundation